Journal of Clinical Endocrinology & Metabolism, Vol 81, 124-129, Copyright © 1996 by Endocrine Society

ARTICLES

Nelson's syndrome associated with a somatic frame shift mutation in the glucocorticoid receptor gene

M Karl, G Von Wichert, E Kempter, DA Katz, M Reincke, H Monig, IU Ali, CA Stratakis, EH Oldfield, GP Chrousos and HM Schulte
Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, USA.

Nelson's syndrome is the appearance and/or progression of ACTH- secreting pituitary macroadenomas in patients who had previously undergone bilateral adrenalectomy for Cushing's disease. Extremely high plasma ACTH levels and aggressive neoplastic growth might be explained by the lack of appropriate glucocorticoid negative feedback due to defective glucocorticoid signal transduction. To study the glucocorticoid receptor (GR) gene in Nelson's syndrome, DNA was extracted from pituitary adenomas and leukocytes of four patients with this condition and amplified by PCR for direct sequence analysis. In one of the tumors, a heterozygous mutation, consisting of an insertion of a thymine between complementary DNA nucleotides 1188 and 1189, was found in exon 2. This frame-shift mutation led to premature termination at amino acid residue 366 of the wild-type coding sequence, excluding the expression of a functioning receptor protein from the defective allele. The mutation was not detected in the sequence of the GR gene in the patient's leukocyte DNA, indicating a somatic origin. By lowering the receptor number in tumorous cells, this defect might have caused local resistance to negative glucocorticoid feedback similar to that caused by the presence of a null allele in a kindred with the generalized glucocorticoid resistance syndrome. P53 protein accumulation, previously reported in 60% of corticotropinomas, could not be detected in any of the four pituitary tumors examined by immunohistochemistry. We suggest that a somatic GR defect might have played a pathophysiological role in the tumorigenesis of the corticotropinoma bearing this mutation.

This article has been cited by other articles:

				G. Assie, H. Bahurel, J. Coste, S. Silvera, M. Kujas, M.-A. Dugue, F. Karray, B. Dousset, J. Bertherat, P. Legmann, et al. Corticotroph Tumor Progression after Adrenalectomy in Cushing's Disease: A Reappraisal of Nelson's Syndrome J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 172 - 179. [Abstract] [Full Text] [PDF]

				M Messager, C Carriere, X Bertagna, and Y de Keyzer RT-PCR analysis of corticotroph-associated genes expression in carcinoid tumours in the ectopic-ACTH syndrome Eur. J. Endocrinol., January 1, 2006; 154(1): 159 - 166. [Abstract] [Full Text] [PDF]

				E R. DE KLOET and R. DERIJK Signaling Pathways in Brain Involved in Predisposition and Pathogenesis of Stress-Related Disease: Genetic and Kinetic Factors Affecting the MR/GR Balance Ann. N.Y. Acad. Sci., December 1, 2004; 1032(1): 14 - 34. [Abstract] [Full Text] [PDF]

				E. F.C. van Rossum and S. W.J. Lamberts Polymorphisms in the Glucocorticoid Receptor Gene and Their Associations with Metabolic Parameters and Body Composition Recent Prog. Horm. Res., January 1, 2004; 59(1): 333 - 357. [Abstract] [Full Text]

				S. Ando, N. J. Sarlis, E. H. Oldfield, and P. M. Yen Somatic Mutation of TR{beta} Can Cause a Defect in Negative Regulation of TSH in a TSH-Secreting Pituitary Tumor J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5572 - 5576. [Abstract] [Full Text] [PDF]

				A. G. Hillmann, J. Ramdas, K. Multanen, M. R. Norman, and J. M. Harmon Glucocorticoid Receptor Gene Mutations in Leukemic Cells Acquired in Vitro and in Vivo Cancer Res., April 1, 2000; 60(7): 2056 - 2062. [Abstract] [Full Text]

				M. Losa, R. L. A. Barzaghi, P. Mortini, A. Franzin, F. Mangili, M. R. Terreni, and M. Giovanelli Determination of the Proliferation and Apoptotic Index in Adrenocorticotropin-Secreting Pituitary Tumors : Comparison between Micro- and Macroadenomas Am. J. Pathol., January 1, 2000; 156(1): 245 - 251. [Abstract] [Full Text] [PDF]

				P. L. M. Dahia and A. B. Grossman The Molecular Pathogenesis of Corticotroph Tumors Endocr. Rev., April 1, 1999; 20(2): 136 - 155. [Abstract] [Full Text]

				S. L. Asa and S. Ezzat The Cytogenesis and Pathogenesis of Pituitary Adenomas Endocr. Rev., December 1, 1998; 19(6): 798 - 827. [Abstract] [Full Text]

				L. Katznelson, J. S. Bogan, J. R. Trob, D. A. Schoenfeld, E. T. Hedley-Whyte, D. W. Hsu, N. T. Zervas, B. Swearingen, M. Sleeper, and A. Klibanski Biochemical Assessment of Cushing's Disease in Patients with Corticotroph Macroadenomas J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1619 - 1623. [Abstract] [Full Text]

				N. A. T. M. Huizenga, P. de Lange, J. W. Koper, R. N. Clayton, W. E. Farrell, A. J. van der Lely, A. O. Brinkmann, F. H. de Jong, and S. W. J. Lamberts Human Adrenocorticotropin-Secreting Pituitary Adenomas Show Frequent Loss of Heterozygosity at the Glucocorticoid Receptor Gene Locus J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 917 - 921. [Abstract] [Full Text]

				P. L. M. Dahia, J. Honegger, M. Reincke, R. A. Jacobs, A. Mirtella, R. Fahlbusch, G. M. Besser, S. L. Chew, and A. B. Grossman Expression of Glucocorticoid Receptor Gene Isoforms in Corticotropin-Secreting Tumors J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1088 - 1093. [Abstract] [Full Text] [PDF]